Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 3, 2026SHILAP Revista de lepidopterologíaOpen Access

In silico assessment of cyanobacterial alkaloids as probable medications against SARS-CoV-2

View Full Paper
Ask AI
Bookmark
Share

Authors

ASAnimesh SenHCHemantha Mani Kumar Chakravarthi ChandaSCSrinivasulu Cheemanapalli

Discussion

Loading...

Member takes

Overview

In silico analysis identifies cyanobacterial alkaloids as potential medications against SARS-CoV-2, indicating new therapeutic options.

Key Points

  • Cyanobacterial alkaloids show potential bioactivity against SARS-CoV-2, indicating possible therapeutic applications.
  • Molecular docking studies provided significant insights, with top candidates demonstrating high affinity, such as 9.3 kcal/mol.
  • Assessing the bioactivity using in silico methods allowed for a systematic evaluation of potential interventions.
  • Further validation in clinical settings is needed to confirm efficacy and safety in human populations.

Cite This Study

Sen et al. (2026) studied this question.

synapsesocial.com/papers/69a75b76c6e9836116a22ca6https://doi.org/10.1016/j.insi.2026.100215
View Full Paper
Ask AI
Bookmark
Share